Petrova Penka

Chief Development Officer at Trillium Therapeutics Inc.

Sold, on record
$280k
Dollars the filings state
Form 4 sales
6
Latest Apr 8, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jan 7, 2021 2021

    Sold 2,708 shares at $14.71 ($40k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($40k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jan 8, 2021 +1 day

    Sold 2,604 shares at $15.50 ($40k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($40k position)0 shares leftFiling

  3. 3 Form 4 sale Trillium Therapeutics Inc.Unusual
    Jan 11, 2021 +3 days

    Sold 508 shares at $15.21 ($8k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($8k position)0 shares leftFiling

  4. 4 Form 4 sale Trillium Therapeutics Inc.Unusual
    Feb 9, 2021 +29 days

    Sold 5,820 shares at $12.78 ($74k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($74k position)0 shares left2.2x usual sizeFiling

  5. 5 Form 4 sale Trillium Therapeutics Inc.Unusual
    Mar 10, 2021 +29 days

    Sold 5,312 shares at $11.08 ($59k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($59k position)0 shares left2x usual sizeFiling

  6. 6 Form 4 sale Trillium Therapeutics Inc.Unusual
    Apr 8, 2021 +29 days

    Sold 5,312 shares at $11.09 ($59k)

    Petrova Penka, Chief Development Officer

    Sold 100% of holdings ($59k position)0 shares left2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Petrova Penka
Source
Apr 8, 2021Apr 9, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale5,312$59k100.0%UnusualSEC
Mar 10, 2021Mar 12, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale5,312$59k100.0%UnusualSEC
Feb 9, 2021Feb 10, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale5,820$74k100.0%UnusualSEC
Jan 11, 2021Jan 13, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale508$8k100.0%UnusualSEC
Jan 8, 2021Jan 12, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale2,604$40k100.0%UnusualSEC
Jan 7, 2021Jan 11, 2021Trillium Therapeutics Inc.Chief Development OfficerForm 4 sale2,708$40k100.0%UnusualSEC